Table 1.

Response of wild-type (+/+), MT-III-deficient (−/−), and MT-III transgenic (TG) mice to kainic acid

GenotypeGenetic backgroundPercent seizingLatency (min)Total convulsion time (sec)Mortality (%)
+/+hybrid7429.3  ± 3.0121  ± 1818
−/−hybrid8621.5  ± 4.1221  ± 251-16043*
TGhybrid7131.5  ± 3.5115  ± 2011
+/+129 Sv7630.6  ± 4.0107  ± 250
−/−129 Sv8820.9  ± 3.0184  ± 3013
  • Hybrid mice were given 25 mg of kainate/kg body weight and congenic mice (129 Sv) were given 35 mg of kainate/kg body weight. Latencies and convulsion times are the means ± SEM, n ≥ 24 for each group.

  • * Significantly greater than +/+ hybrid mice;p < 0.05, χ2 analysis.

  • F1-160 Significantly greater than +/+ hybrid mice; p < 0.01, unpaired t test.